or Try an Advanced Search...

    Johnson & Johnson Stocks List

    Symbol Grade Name % Change
    KVUE F Kenvue Inc. 0.38
    JNJ F Johnson & Johnson -0.23
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Household & Personal Products
    Related Stock Lists: Pain S&P 500 Skin Care Allergy Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Care Products Contact Lens Contact Lenses Cough Counter Pharmaceutical Products Diagnostic Products Dow Jones Component Energy Products Gastrointestinal General Surgery Glucose Hematology Immunology

    Related ETFs - A few ETFs which own one or more of the above listed Johnson & Johnson stocks.

    Symbol Grade Name Weight
    IHE B iShares U.S. Pharmaceutical ETF 22.53
    IPO B Renaissance IPO ETF 9.8
    FLV D American Century Focused Large Cap Value ETF 9.13
    HDV C iShares High Dividend ETF 7.03
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 6.56
    View all Johnson & Johnson ETFs...
    Compare ETFs
    Compare FLV to HDV Compare HDV to FTXH Compare IHE to FTXH

        Johnson & Johnson Stocks Recent News

        Date Stock Title
        Jul 3 JNJ Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
        Jul 3 JNJ Johnson & Johnson: Put Selling Can Yield A Potential 9.8% Return
        Jul 3 JNJ How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
        Jul 3 JNJ Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
        Jul 3 JNJ Johnson & Johnson gains FDA and EC approvals for TB treatment
        Jul 3 JNJ Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
        Jul 2 JNJ Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
        Jul 2 JNJ Court Rules Against Johnson & Johnson In Talcum Powder Cancer Study Case
        Jul 2 JNJ J&J says Carvykti beat standard drugs in late-stage blood cancer trial
        Jul 2 JNJ CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study
        Jul 1 JNJ 5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
        Jul 1 JNJ J&J looks to challenge argenx’s Vyvgart with positive Phase III data
        Jul 1 JNJ 3 Magnificent Stocks Retirees Can Buy and Hold Forever
        Jul 1 JNJ Merck (MRK) Gets CHMP Nod for PAH Drug Winrevair in Europe
        Jun 30 JNJ 2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
        Jun 29 JNJ J&J talc claimants lose bid to block company's bankruptcy bid
        Jun 29 JNJ 4 Cheap Stocks to Buy in July
        Jun 28 JNJ How Medicare drug price negotiations could hit pharma stocks
        Jun 28 JNJ J&J reports positive phase 3 data for nipocalimab for neuromuscular disease
        Jun 28 JNJ Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients
        Related Industries: Drug Manufacturers - Major Household & Personal Products
        Related Stock Lists: Pain S&P 500 Skin Care Allergy Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Care Products Contact Lens Contact Lenses Cough Counter Pharmaceutical Products Diagnostic Products Dow Jones Component Energy Products Gastrointestinal General Surgery Glucose Hematology Immunology
        Johnson & Johnson

        Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
        Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015.
        Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.

        More about Johnson & Johnson
        Browse All Tags